ARCHIVES
VOL. 8, ISSUE 4 (2023)
Development of novel agricultural products with pharmaceutical properties
Authors
Dr. Emilie Dubois, Andreas Müller, Dr. Lucia Rodríguez
Abstract
This study explores the development of novel agricultural products with
pharmaceutical properties, focusing on the bioactive compounds present in both
traditional and genetically modified crops. Plants such as Solanum
lycopersicum (tomato), Capsicum annuum (bell
pepper), Glycine max (soybean), and Brassica oleracea (cabbage)
were evaluated for their content of flavonoids, terpenoids, and alkaloids.
Genetically modified variants of these crops, engineered for enhanced bioactive
compound production, were also studied. The results demonstrated that the
genetically modified crops exhibited up to a 40% increase in bioactive compound
content compared to their wild-type counterparts. These compounds showed
significant antimicrobial activity, with inhibition zones ranging from 12 to 18
mm against Escherichia coli and Bacillus subtilis.
Cytotoxicity assays revealed that the genetically modified crops also induced
higher rates of apoptosis in cancer cell lines, with IC50 values as low as 25.6
µg/mL for GM tomato. These findings highlight the potential of genetically
modified agricultural products as sustainable sources of therapeutic compounds,
with applications in treating cancer and microbial infections. Furthermore,
agricultural waste is identified as a potential underexploited source of
bioactive compounds for pharmaceutical use.
Pages:57-60
How to cite this article:
Dr. Emilie Dubois, Andreas Müller, Dr. Lucia Rodríguez "Development of novel agricultural products with pharmaceutical properties". International Journal of Research in Pharmacy and
Pharmaceutical Sciences, Vol 8, Issue 4, 2023, Pages 57-60
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.